UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
TECH LABORATORIES, INC.
(Name of Issuer)
COMMON STOCK, $.01 PAR VALUE
(Title of Class of Securities)
878249101
(CUSIP Number)
CRAIG H. EFFRAIN, ESQ.
STURSBERG & VEITH
405 LEXINGTON AVENUE, SUITE 4949, NEW YORK, NY 10174-4902
(212) 922-1177
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
2/3/00
(Date of Event which Requires Filing
of this Statement)
1 of 5
<PAGE>
If the filing person has previously filed a statement of Schedule 13G to report
the acquisition which is the subject of the Schedule 13D, and is filing this
schedule because of Rule 13d-1(b)(3) or (4), check the following box [_].
Note: Schedules filed in the paper format shall include a signed original and
five copies of the schedule, including all exhibits. See ss.240.13d-7 for other
parties to whom copies are to be sent.
* The remainder of this cover page shall be filed out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which
would alter the disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
(Continued on following page(s))
2 of 5
<PAGE>
CUSIP No. 13D
878249101
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
BERNARD M. CIONGOLI
154366764
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [ ]
(b) [ ]
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
OO SHARES WERE ACQUIRED OVER LAST SEVERAL YEARS IN CONSIDERATION OF
SERVICES RENDERED ON BEHALF OF ISSUER. FILING SCHEDULE 13D NOW
PURSUANT TO ISSUER'S REGISTRATION STATEMENT BEING DECLARED
EFFECTIVE ON FEBRUARY 3, 2000
- --------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) OR 2(e) [_]
- --------------------------------------------------------------------------------
3 of 5
<PAGE>
6 CITIZENSHIP OR PLACE OF ORGANIZATION
U.S.A.
- --------------------------------------------------------------------------------
NUMBER OF 7 SOLE VOTING POWER
SHARES 820,000
BENEFICIALLY --------------------------------------------------------------
OWNED BY 8 SHARED VOTING POWER
EACH -0-
REPORTING --------------------------------------------------------------
PERSON 9 SOLE DISPOSITIVE POWER
WITH 820,000
--------------------------------------------------------------
10 SHARED DISPOSITIVE POWER
-0-
- --------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
820,000
- --------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
[ ]
- --------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
21.86%
- --------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
IN
- --------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
4 of 5
<PAGE>
Schedule 13D
Item 1. Security and Issuer
This statement relates to the Common Stock, $.01 Par Value of Tech
Laboratories, Inc., 955 Belmont Avenue, North Haledon, NJ 07508.
Item 2. Identity and Background
(a) Bernard M. Ciongoli
(b) Tech Laboratories, Inc.
955 Belmont Avenue
North Haledon, NJ 07508
(c) Mr. Ciongoli is the president of Tech Laboratories, Inc.
(d) None
(e) None
(f) USA
Item 3. Source and Amount of Funds or Other Consideration
Mr. Ciongoli received the shares over last several years in consideration
of services rendered on behalf of the Issuer. The Issuer filed a registration
statement on Form SB-2 and had it declared effective on February 3, 2000.
Item 4. Purpose of Transaction
See Item 3.
Item 5. Interest in Securities of the Issuer
See Items 7 through 13 of the cover page to this Schedule 13D. As of the
date of this report Mr. Ciongoli beneficially owned 820,000 shares. Such number
of shares include 200,000 shares of common stock issuable upon exercise of
options that are immediately exercisable. To the knowledge of Bernard M.
Ciongoli, the Issuer has 3,575,660 shares of common stock, par value $.01 per
share outstanding on the date hereof.
Item 6. Contracts, Arrangements, Understandings or Relationships with
Respect to Securities of the Issuer.
None
Item 7. Material to be Filed as Exhibits
None
5 of 5
<PAGE>
Signature
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
Date: February 16, 2000 /s/ BERNARD M. CIONGOLI
-----------------------------------
Signature
BERNARD M. CIONGOLI
-----------------------------------
Name/Title
